Loading...
BVMF
BALM4
Market cap31mUSD
Jul 15, Last price  
16.04BRL
Name

Baumer SA

Chart & performance

D1W1MN
BVMF:BALM4 chart
P/E
8.68
P/S
0.73
EPS
1.85
Div yield, %
28.05%
Shrs. gr., 5y
Rev. gr., 5y
-8.09%
Revenues
214m
+9.95%
65,106,00065,303,00074,055,00085,202,00094,812,00093,512,00099,746,000108,697,000116,297,000112,044,000113,105,000109,754,000119,803,000149,310,000325,946,000267,640,000329,088,000169,950,000194,386,000213,729,000
Net income
18m
-42.81%
5,421,0001,833,0004,215,0001,980,0003,717,0006,933,0008,458,00013,128,00011,497,00014,352,0003,016,000675,0002,753,0004,194,00016,431,00010,132,0005,709,0008,941,00031,606,00018,077,000
CFO
67m
+113.62%
578,0003,240,000201,0007,075,0001,503,0008,867,0005,034,0004,694,000766,0005,534,000-2,870,00014,527,00026,325,00017,635,0003,133,00025,593,00031,278,00066,815,000
Dividend
May 04, 20260.82 BRL/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Baumer SA engages in the development, manufacture, and sale of hospital, odontology, and health industry solutions and equipment. It operates through the following segments: Orthopedics, Hospital, Genius, and Castanho. The Orthopedics segment manufactures and sells orthopedic implants and instruments. The Hospital segment manufactures and markets equipment for hospitals. pharmaceutical, chemical, cosmetic, and food industry. The Genius segment deals with biomaterials area. The Castanho segment provides equipment for hospital, industrial, and hotel laundry. The company was founded by Manoel Amaral Baumer in July, 1952 and is headquartered in Mogi Mirim, Brazil.
IPO date
Jun 06, 1995
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT